Substance
BUPROPION HYDROCHLORIDE
Global reference: every product and company linked to this substance.
- cas: 31677-93-7
- ncit: C1317
- pubchem_cid: 62884
- rxnorm: 203204
- unii: ZG7E5POY8O
Budeprion · Bupropion hydrochloride [JAN] · Bupropion hydrochloride [USAN] · Bupropion hydrochloride [WHO-DD] · BW-323 · BW323 · CONTRAVE COMPONENT BUPROPION HYDROCHLORIDE · MYSIMBA · NSC-315851 · WELLBUTRIN
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| AXSOME THERAPEUTICS INC. COMMON STOCK | AUVELITY | Q2 2026 | $180.3M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (7)
- AUVELITY · AXSOME THERAPEUTICS INC. COMMON STOCK
- BUPROPION HYDROCHLORIDE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- WELLBUTRIN · GSK PLC AMERICAN DEPOSITARY SHARES (EACH REPRESENTING TWO ORDINARY SHARES)
- WELLBUTRIN SR · GSK PLC AMERICAN DEPOSITARY SHARES (EACH REPRESENTING TWO ORDINARY SHARES)
- WELLBUTRIN XL · BAUSCH HEALTH COMPANIES INC. COMMON STOCK
- ZYBAN · GSK PLC AMERICAN DEPOSITARY SHARES (EACH REPRESENTING TWO ORDINARY SHARES)